Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDURSULFASE Cause Post procedural complication? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Post procedural complication have been filed in association with IDURSULFASE (ELAPRASE). This represents 0.6% of all adverse event reports for IDURSULFASE.

19
Reports of Post procedural complication with IDURSULFASE
0.6%
of all IDURSULFASE reports
7
Deaths
12
Hospitalizations

How Dangerous Is Post procedural complication From IDURSULFASE?

Of the 19 reports, 7 (36.8%) resulted in death, 12 (63.2%) required hospitalization, and 2 (10.5%) were considered life-threatening.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does IDURSULFASE Cause?

Pyrexia (524) Product dose omission issue (450) Inappropriate schedule of product administration (371) Cough (263) Infusion related reaction (241) Pneumonia (232) Death (222) Dyspnoea (202) Influenza (200) Covid-19 (197)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) TREPROSTINIL (174) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157)

Which IDURSULFASE Alternatives Have Lower Post procedural complication Risk?

IDURSULFASE vs IFOSFAMIDE IDURSULFASE vs IGURATIMOD IDURSULFASE vs ILOPERIDONE IDURSULFASE vs ILOPROST IDURSULFASE vs IMATINIB

Related Pages

IDURSULFASE Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication IDURSULFASE Demographics